|
 |
PramlintideThis page contains recent news articles, when available, and an overview of Pramlintide but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.Amylin has developed and gained approval for two first-in-class medicines for diabetes, SYMLIN® (pramlintide acetate) injection and BYETTA® (exenatide) ... PR Newswire (press release) Amylin Pharmaceuticals to Give Presentation at Deutsche Bank 2009 Biotech ... - Dec 10, 2009 Amylin has developed and gained approval for two first-in-class medicines for diabetes, SYMLIN® (pramlintide acetate) injection and BYETTA® (exenatide) ... TransWorldNews (press release) Takeda, Amylin to Co-Develop Obesity Drugs - Nov 1, 2009 The agreement includes Amylin's pramlintide/metreleptin and davalintide, which are in Phase II studies in the United States. Takeda will lead development ... ABC News Amylin Pharmaceuticals Highlights New Data Supporting Therapeutic Potential of ... - Oct 19, 2009 Phase 2 data from the pramlintide/metreleptin combination treatment clinical program will be the subject of a late-breaking oral presentation. ... Reuters Combination drugs for weight loss - Oct 29, 2009 ...and adiposity signaling, significantly reduced body weight when compared with placebo or compared with therapy with pramlintide or metreleptin alone. ... TheHeart.Org AMLN, Green Light from FDA to Its BYETTA for Expanded Use - Oct 31, 2009 AMLN has developed and gained approval for two first-in-class medicines for diabetes, SYMLIN® (pramlintide acetate) injection and BYETTA® (exenatide) ... TransWorldNews (press release) Human Genome rallies, GTX craters - Nov 2, 2009 Amylin currently has two such products in Phase II development, pramlintide/metreleptin and davalintide. Under the deal, Takeda will pay Amylin $75 million ... MarketWatch Amylin Pharmaceuticals to Present at the 18th Annual Credit Suisse Healthcare ... - Nov 5, 2009 Amylin has developed and gained approval for two first-in-class medicines for diabetes, SYMLIN® (pramlintide acetate) injection and BYETTA® (exenatide) ... Reuters Amylin Pharmaceuticals, Inc. Q3 2009 Earnings Call Transcript - Oct 20, 2009 In the third quarter we announced positive top line Phase II data from pramlintide/metreleptin study. This study is continuing and data from the extension ... Seeking Alpha (blog) REG-Lilly (Eli) & Co: STATEMENT ON FDA'S BYETTA (EXENATIDE) INJECTION UPDATE - Nov 2, 2009 Amylin has developed and gained approval for two first-in-class medicines for diabetes, SYMLIN® (pramlintide acetate) injection and BYETTA® (exenatide) ... Reuters Amylin Pharmaceuticals Reports Third Quarter Financial Results - Oct 20, 2009 Amylin has developed and gained approval for two first-in-class medicines for diabetes, SYMLIN® (pramlintide acetate) injection and BYETTA® (exenatide) ... Reuters Week of Nov. 2, 2009: Eli Lilly Opens Biotech Center; Johnson & Johnson ... - Nov 5, 2009 The agreement includes products to be developed from Amylin's pipeline, including pramlintide/metreleptin and davalintide, which are compounds currently in ... Pharmaceutical Technology Magazine Amylin Pharmaceuticals Inc. Reports Operating Results (10-Q) - Nov 5, 2009 ...the completion of our Duration-2, Duration-3 and pramlintide/leptin clinical trials, as well as efficiencies driven by our reduced cost structure. ... GuruFocus.com DotW: Sesame Street - Nov 6, 2009 1, Takeda announced it was teaming up with Amylin, taking two obesity candidates off the table: pramlintide/metreleptin and davalintide. ... The IN VIVO Blog (blog) Amylin Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and ... - Nov 9, 2009 The BYETTA (exenatide) injection and SYMLIN (pramlintide acetate) injection are the two medicines marketed by the company to treat diabetes. ... PR-Inside.com (Pressemitteilung) æ—¥ 다케다, 아밀린과 밀월여행 - Nov 3, 2009 ...ì?´ë²ˆ 계약ì—?는 아밀린ì?˜ 비만ì¦? ì¹˜ë£Œì œ '프램린타ì?´ë“œ(pramlintide)' '다발린타ì?´ë“œ(davalintide)'등과 양사ì?˜ 비만ì¦?ì¹˜ë£Œì œ 연구ì—?ì„œ ìƒ?성ë?˜ëŠ” 화합물ë?„ 들어 있다. ... 헬스코리아뉴스 Amylin Pharma与æ¦ç”°è?¯å“?ç¾ç½²æŽˆæ?ƒå??è®® - Nov 2, 2009 ...å??议包括开å?‘Amylin候选è?¯å“?，涵盖pramlintide/metreleptin与davalintide，这些化å?ˆç‰©ç›®å‰?进行第二阶段实验，治疗肥胖症。 å…?责声明：本文仅代表作者个人观点，与凤凰 ... 凤凰网 æ¦ç”°è–¬å“?å·¥æ¥ã?Œç±³å›½ï¼¡ï½?ｙｌｉｎ社ã?¨ã?®æŠ—肥満薬ã?®é–‹ç™ºãƒ»è²©å£²å¥‘ç´„ - Nov 1, 2009 ...今回ã?®å¥‘ç´„ã?¯ã€?肥満症を対象ã?¨ã?—米国ã?§è‡¨åºŠç¬¬2相試験を実施ä¸ã?®ï¼°ï½’ï½?ï½?ｌｉｎｔｉｄｅï¼?ï¼ï½…ｔｒｅｌｅï½?ｔｉｎã?Šã‚ˆã?³ï¼¤ï½?ï½–ï½?ｌｉｎｔｉｄｅをå?«ã‚€ã‚¢ãƒŸãƒªãƒ³ç¤¾ã?®é–‹ç™º ... サーチナニュース Комбинирана медикаментозна терапиÑ? е ефективна за отÑ?лабване 03 ноември 2009 - Nov 3, 2009 Ð’ първото проучване е било уÑ?тановено, че комбинираната пептидна терапиÑ? Ñ? pramlintide и metreleptin води до значително намалÑ?ване на теглото в Ñ?равнение Ñ? ... DoctorBG.com 다께다/아밀린, ë¹„ë§Œì¹˜ë£Œì œ ê³µë?™ê°œë°œ í•©ì?˜ - Nov 3, 2009 ...김윤ì˜? 기ìž? ì?¼ë³¸ 거대 ì œì•½ì‚¬ 다께다와 ë¯¸êµ ì•„ë°€ë¦°(Amylin)사는 비만치료 ì‹ ì•½ pramlintide/metreleptin ë°? davalintide 개발 ë°? ìƒ?용화를 위한 10ì–µ 달러 규모ì?˜ ... 메디포뉴스 Takeda compra medicamentos à Amylin - Nov 3, 2009 ...a farmacêutica japonesa vai pagar 75 milhões de dólares adiantados por fármacos da californiana Amylin que incluem o pramlintide/metreleptin eo ... RCM Pharma Takeda beli paten obat obesitas - Nov 2, 2009 Takeda yang berbasis di Osaka menyatakan akan membayar uang muka senilai US$75 juta untuk pembelian paten obat, yang mencakup Amylin pramlintide/metrelepin ... Bisnis Indonesia Does addition of pramlintide to basal insulin improve glycemic... - Oct 29, 2007 Riddle M et al. (2007) Pramlintide improved glycemic control and reduced weight in patients with type 2 diabetes using basal insulin. ... Nature.com Is pramlintide a safe and effective adjunct therapy for patients with... - Dec 8, 2006 Edelman S et al. (2006) A double-blind, placebo-controlled trial assessing pramlintide treatment in the setting of intensive insulin therapy in type 1 ... Nature.com Learn about Pramlintide Injection from Consumer Reports Health. - Jan 5, 2007 You will use pramlintide with mealtime insulin to control your blood sugar levels. When you use ... Full Alert. Pramlintide is used with mealtime insulin to ... consumerreports.org RedHerring.com ~ The Business of Technology - Oct 25, 2006 Despite the announcement of an expansion in pramlintide testing, shares of Amylin were selling for $44.20 on Wednesday afternoon, down $0.65 from its ... Red Herring … -Ranging Clinical Study Of Pramlintide/Metreleptin Combination Trea - May 6, 2008 Pramlintide is a synthetic analog of amylin, a neurohormone secreted by the pancreas ... To date, more than 6000 individuals have received pramlintide in ... Medical News Today - Medical News Today (press release) Setting Up For A Diabetes Squeeze - Jun 8, 2005 Early clinical data for another Amylin candidate, Pramlintide, also shows potential for use as a weight-loss agent. Amylin shares closed Tuesday at $15.05, ... Forbes Taking a Shot at Weight Loss - Jun 8, 2007 The hormone, pramlintide, marketed under the name Symlin, is currently used to treat ... "We are very intrigued to find that pramlintide can actually have ... ABC News Indication: Symlin (pramlintide) is indicated to be given at mealtime... - Mar 16, 2005 Type 1 diabetes, as an adjunct treatment in patients who use mealtime insulin therapy and who have failed to achieve desired glucose control despite optimal ... Medscape Pramlintide Obesity Study Results Positive - Feb 9, 2006 SAN DIEGO, Feb. 9 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals, Inc. today announced positive results from a 16-week Phase 2 dose-ranging study ... RedOrbit Exenatide and Pramlintide - Oct 29, 2007 ...by Stacy Griffin, Pharm.D., and John Borders, MD. Tips for use. Your response to exenatide and to all other diabetes medicines will be better if you eat ... Diabetes Self Management Amylin weight-loss drug is promising. - Jun 4, 2005 Pramlintide is the same drug in Amylin's therapy known as Symlin. ... The patients taking pramlintide for the obesity study were given about double the ... Free with registration - San Diego Union - Tribune - AccessMyLibrary.com Diabetes drug may help treat obesity - Sep 10, 2008 Pramlintide, currently approved by the FDA for diabetes to take in combination with insulin to ... Previous research also linked pramlintide to weight loss, ... Reuters UK SD's Amylin reports diet-drug success - Nov 16, 2007 Amylin Pharmaceuticals said yesterday that patients in a 24-week trial of its obesity therapy pramlintide lost an average of 25 pounds. ... San Diego Union - Tribune - San Diego Union Tribune Pramlintide ( Systemic). - Feb 1, 2006 Pramlintide (PRAM-lin-tide) is used to control blood sugar in patients with type 1 and type 2 diabetes. It is always used with insulin. ... Free with registration - USP DI-Volume II, Advice for the... - AccessMyLibrary.com Pramlintide ( Systemic).(Drug overview) - Aug 1, 2006 Pramlintide (PRAM-lin-tide) is used to control blood sugar in patients with type 1 and type 2 diabetes. It is always used with insulin. ... Free with registration - USP DI-Volume II, Advice for the... - AccessMyLibrary.com Who Are the Canidates for Pramlintide (Smylin®) - Oct 18, 2005 When should primary care providers consider prescribing pramlintide (Symlin, Amylin) to their patients with diabetes? The neuron-hormone amylin was long ... Diabetes In Control Pramlintide-Related Improvements in Diabetes Benefit Patients'... - Jun 8, 2008 By Jill Stein. SAN FRANCISCO -- June 8, 2008 -- The initiation of pramlintide treatment in type 2 diabetics is associated with a reduction in distress, ... DG News Hormone That Signals Fullness Also Curbs Fast Food Consumption And … - Jun 10, 2007 The research, entitled "Pramlintide treatment reduces 24-hour caloric intake ... Pramlintide is the synthetic form of amylin, a satiety hormone produced by ... sciencedaily.com … Release: Amylin Presents Results From Pramlintide Obesity Program... - Jun 3, 2005 Amylin Presents Results From Pramlintide Obesity Program at 14th Annual European Congress on Obesity. from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research Diabetes drug helps shed pounds - Sep 23, 2008 The drug, pramlintide, received US regulatory approval in 2005 for the treatment of ... Pramlintide is a synthetic version of a natural hormone made in the ... Science News Press Release: Pramlintide and Leptin Combination Treatment … - Nov 15, 2007 Pramlintide and Leptin Combination Treatment Demonstrates 12.7 Percent Weight Loss in 24-Week Clinical Obesity Study. from PR Newswire. Pay-Per-View - PR Newswire - HighBeam Research Amylin's pramlintide performs well in Ph II.(Amylin Pharmaceuticals... - Feb 20, 2006 USA-based Amylin Pharmaceuticals says that results from a Phase II clinical study of its developmental obesity drug pramlintide demonstrate the compound's ... $4.95 - Pharma Marketletter - ECNext Acomplia Report - Amylin Weight-Loss Drug Shows Promise - Nov 8, 2005 Pramlintide is a synthetic analog of human amylin, a hormone known to play ... The patients taking pramlintide for the obesity study were given about twice ... Acomplia Report Therapies for diabetes: pramlintide and exenatide. - Jun 15, 2007 The American Diabetes Association currently recommends an A1C goal of less than 7 percent. However, many patients are unable to achieve this goal by using ... $4.95 - American Family Physician - ECNext Exenatide (Byetta) Drug Evaluation. - Mar 1, 2006 Pramlintide is a synthetic analogue of human amylin that is synthesized by ... Pramlintide is co-secreted with insulin in response to food intake. ... Free with registration - Drug Formulary Review - AccessMyLibrary.com Symlin.(New molecular entities/biologics) - Apr 1, 2005 Pramlintide was approved on March 16, 2005, for use in conjunction with ... The efficacy of pramlintide was evaluated in several clinical trials that ... Free with registration - Formulary - AccessMyLibrary.com Pramlintide Used To Promote Weight Loss - Sep 11, 2007 Treatment with the amylin analog pramlintide has been shown to reduce weight in obese patients, according to researchers. ... Diabetes In Control Amylin Pharmaceuticals, Inc. at Credit Suisse Annual Health Care … - Nov 16, 2006 Pramlintide plus Leptin, we presented recently some very compelling preclinical data showing synergistic effects of Pramlintide with Leptin, also looking at ... Free with registration - America's Intelligence Wire - AccessMyLibrary.com Obesity market set for explosive growth, says report - Mar 25, 2008 Market growth will be fueled by a number of emerging therapies, the report said, including Arena Pharmaceuticals' lorcaserin and Amylin's pramlintide/leptin ... Medical Marketing & Media - Medical Marketing and Media How to take Pramlintide Injection from Consumer Reports Health. - Jan 5, 2007 You will use pramlintide with mealtime insulin to control your blood sugar levels. When you use ... Full Alert. tell your doctor and pharmacist if you are ... consumerreports.org SYMLIN® (pramlintide acetate) Injection - Jun 28, 2005 Symlin® injection is an antihyperglycemic drug for use in patients with diabetes treated with insulin. Pramlintide is a synthetic analog of human amylin, ... Diabetes In Control Press Release: Pramlintide Obesity Study Results Positive. - PR … - Feb 9, 2006 Pramlintide Obesity Study Results Positive. from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research Diabetes drug may help obese people eat less - Jun 12, 2007 Pramlintide is a synthetic version of the human hormone amylin, ... San Diego-based Amylin Pharmaceuticals makes pramlintide, which is sold under the trade ... Reuters UK Type 1 Diabetes Treatment - Type 1 Diabetes Health Information - NY … - Jun 17, 2008 Pramlintide (Symlin) is a new type of injectable drug that can help control ... Pramlintide is injected before meals and can help lower blood sugar levels ... New York Times New drug boosts insulin to control blood sugar.(Rx CARE) - Apr 18, 2005 Pramlintide is a synthetic analog of human amylin, a neuroendocrine hormone. Unlike most insulin products, pramlintide will be available only by ... Free with registration - Drug Topics - AccessMyLibrary.com Diabetes drug promising as aid to weight loss - Sep 5, 2007 Pramlintide, sold in the United States under the trade name Symlin, ... The participants were randomly assigned to get pramlintide or an inactive placebo, ... Reuters Research and Markets: Amylin's Pramlintide Acetate (Symlin) Recently ... - Mar 27, 2006 Research and Markets (http://www.researchandmarkets.com/reports/c32028) has announced the addition of The Impact of Islet Cell Transplantation on the Type 1 ... RedOrbit FinancialContent.com - Stock Quotes and Business News - May 5, 2008 Pramlintide is a synthetic analog of amylin, a neurohormone secreted by the pancreas ... To date, more than 6000 individuals have received pramlintide in ... cbs11tv.com Article: Amylin's Pramlintide fights obesity.(BIOTECH) - San Diego … - Jun 13, 2005 Amylin's Pramlintide fights obesity.(BIOTECH) ... find San Diego Business Journal articles. Amylin's Pramlintide Fights Obesity: San Diego-based diabetes ... Pay-Per-View - San Diego Business Journal - HighBeam Research Taking Pramlintide Injection from Consumer Reports Health. - Jan 5, 2007 You will use pramlintide with mealtime insulin to control your blood sugar levels. When you use ... Full Alert. Pramlintide may cause side effects. ... consumerreports.org Amylin's Pramlintide fights obesity.(BIOTECH) - Jun 13, 2005 Amylin's Pramlintide Fights Obesity: San Diego-based diabetes drug maker Amylin Pharmaceuticals Inc.'s spring season is blooming with good news. ... $4.95 - San Diego Business Journal - ECNext Amylin Pharmaceuticals Expands Clinical Program in Obesity. - Oct 24, 2006 This integrated approach to obesity therapy is based on extensive clinical experience with the analog of the human hormone, amylin, called pramlintide, ... Free with registration - PR Newswire - AccessMyLibrary.com pramlintide Amylin marketed, USA (diabetes).(Brief Article) - Jul 18, 2005 During May 2005 Amylin launched pramlintide (SYMLIN) in the USA. ... pramlintide, tripro-amylin, pramlintide acetate, AC 137, AC 0137, SYMLIN, NORMYLIN, ... Pay-Per-View - R & D Focus Drug News - Factiva, from Dow Jones Q4 2005 Amylin Pharmaceuticals, Inc. Earnings Conference Call - Final. - Feb 9, 2006 And today, along with our earnings release, we've announced the positive results of our most recent obesity study with pramlintide. ... Free with registration - Fair Disclosure Wire - AccessMyLibrary.com Inside Drugmakers' War on Fat - Mar 6, 2008 The company was founded in 1987 on the discovery of pramlintide, ... Throughout the ordeal, Amylin kept focused on an edge pramlintide had over other ... BusinessWeek Hormone Curbs Fast Food Consumption and Tendency to Binge Eat - Jun 7, 2007 The research, entitled "Pramlintide treatment reduces 24-hour caloric intake ... Pramlintide is the synthetic form of amylin, a satiety hormone produced by ... DG News Hormone Curbs Fast Food Consumption and Tendency to Binge Eat - Jun 5, 2007 The research, entitled "Pramlintide treatment reduces 24-hour caloric intake ... Pramlintide is the synthetic form of amylin, a satiety hormone produced by ... newswise.com DTC ads subjected to more restrictions: some campaigns are now being ... - May 2, 2005 Symlin should not be used if patients cannot tell when their blood sugar is low, have gastroparesis (slow stomach emptying) or are allergic to pramlintide ... Free with registration - Chain Drug Review - AccessMyLibrary.com Amylin Pharmaceuticals to Present at BIOCOM Investor Conference and … - Nov 9, 2006 Amylin has developed and gained approval for two first-in-class medicines for diabetes, SYMLIN(R) (pramlintide acetate) injection and BYETTA(R) (exenatide) ... Free with registration - PR Newswire - AccessMyLibrary.com Hormone That Signals We Are Full When Eating Also Curbs Fast Food … - Jun 19, 2007 The research, entitled "Pramlintide treatment reduces 24-hour caloric intake ... Pramlintide is the synthetic form of amylin, a satiety hormone produced by ... Virtual Medical Centre - The Virtual Medical Centre Exenatide and Pramlintide - Oct 29, 2007 ...by Stacy Griffin, Pharm.D., and John Borders, MD. The timing of exenatide doses is very important. It must be taken between 1 to 60 minutes before a meal. ... Diabetes Self Management Amylin Pharmaceuticals (AMLN) CEO to Ring the NASDAQ Stock Market … - Oct 20, 2006 Amylin has developed and gained approval for two first-in-class medicines for diabetes, SYMLIN(R) (pramlintide acetate) injection and BYETTA(R) (exenatide) ... primezone.com Amylin Pharmaceuticals to Present at BIOCOM Investor Conference. - Oct 29, 2007 Amylin has developed and gained approval for two first-in-class medicines for diabetes, SYMLIN(R) (pramlintide acetate) injection and BYETTA(R) (exenatide) ... Free with registration - PR Newswire - AccessMyLibrary.com Amylin Pharmaceuticals Appoints Marcea Bland Lloyd Senior Vice … - Feb 6, 2007 Amylin has developed and gained approval for two first-in-class medicines for diabetes, SYMLIN(R) (pramlintide acetate) injection and BYETTA(R) (exenatide) ... Free with registration - PR Newswire - AccessMyLibrary.com Drug, lifestyle combo promotes weight loss.(Obesity) | Article from... - Oct 1, 2008 Pramlintide treatment combined wwith lifestyle intervention resulted in sustained weight loss at 12 months in... Pay-Per-View - Family Practice News - HighBeam Research Amylin's 2nd-qtr loss narrows 32% to $26.6M.(Amylin Pharmaceuticals … - Aug 15, 2005 ...million for Symlin (pramlintide acetate) injection, a diabetes therapy for use with mealtime insulin; both were launched during the reporting period. ... Pay-Per-View - Pharma Marketletter - Factiva, from Dow Jones Orlistat, Lifestyle Counseling Help Maintain 3-Year Weight Loss... - Oct 24, 2006 Meanwhile, another study suggested that pramlintide is a promising obesity treatment. In earlier studies that omitted lifestyle interventions, pramlintide, ... Medscape Amylin raises $176m to fund Symlin, exenatide.(Monday, January 24)( … - Jan 31, 2005 The sale's per-share price represented a slight discount to the prior day's $22.26 closing bid on the stock For Symlin (pramlintide acetate), ... Pay-Per-View - BioWorld Week - Factiva, from Dow Jones Diabetes; New data from Switzerland and the United States lluminates ... - May 10, 2006 Study 2: Investigators review the use of pramlintide for the treatment of type ... Pramlintide, a synthetic amylin analogue, is approved by the US Food and ... Pay-Per-View - Life Science Weekly - Factiva, from Dow Jones Amylin Pharmaceuticals to Present at Cowen and Company Global … - Nov 1, 2006 Amylin has developed and gained approval for two first-in-class medicines for diabetes, SYMLIN(R) (pramlintide acetate) injection and BYETTA(R) (exenatide) ... $4.95 - PR Newswire - ECNext NO1.뉴미디어'마ì?´ë?°ì?¼ë¦¬ - Sep 11, 2008 ...체중ê°?량프로그램과 ìƒ?í™œìŠµê´€ê°œì„ ì—? 혈당ì?„ 낮추는 FDAì?˜ 승ì?¸ì?„ ë°›ì?€ 약물ì?¸ 프람린 타ì?´ë“œ(pramlintide)를 ë³‘í–‰í• ì‹œ 비만ì?„ 치료하는ë?° 효과ì ?ì?¸ 것으로 나타났다. ... 마ì?´ë?°ì?¼ë¦¬ Clinical Pipeline Update; Pharmaceutical firm provides update on... - Jan 10, 2005 Included in the presentation were new data from its pramlintide (AC137) obesity program ... Approximately 90% of subjects receiving pramlintide were able to ... Pay-Per-View - Clinical Trials Week - Factiva, from Dow Jones Clinical Pipeline Update; Pharmaceutical firm provides update on... - Jan 15, 2005 Included in the presentation were new data from its pramlintide (AC137) obesity program ... Approximately 90% of subjects receiving pramlintide were able to ... Pay-Per-View - Obesity, Fitness & Wellness Week - Factiva, from Dow Jones Amylin Expands Obesity Drug Trials - Oct 24, 2006 Despite the announcement of an expansion in pramlintide testing, shares of Amylin were selling for $44.20 on Wednesday afternoon, down $0.65 from its ... Red Herring Article: FDA warning about Amylin's diabetes drug sends stock down.( … - Aug 25, 2008 III clinical studies of its diabetes drug candidate, pramlintide, to ... PARADIGM (Pramlintide for Amylin Replacement: Adjunct for Diabetes ... studies ... Pay-Per-View - San Diego Business Journal - HighBeam Research Analysis: Sanofi loss upsets obesity field. - Jun 14, 2007 Zimulti "would have competed against Amylin's pramlintide too, ... This is because pramlintide is already approved for treating diabetes under the name ... Free with registration - UPI Health Business - AccessMyLibrary.com FDA Approvals: Symlin, Mycamine, Fluzone - Mar 24, 2005 On March 16, the FDA approved pramlintide acetate injection (Symlin, ... Pramlintide is an amylinomimetic agent that modulates gastric emptying, ... Medscape Press Release: Use of Mealtime SYMLIN(R) Compared to Rapid-Acting … - Jun 9, 2008 Drug Administration (FDA) has approved SYMLIN(R) (pramlintide acetate) injection ... conjunction with insulin to treat diabetes. ... Pay-Per-View - PR Newswire - HighBeam Research Amylin testing diet drug to shed weight in humans. - Jun. 21, 2006 - Jun 21, 2006 Tests on the pramlintide-leptin combo are still in their early stages, ... Baron said that pramlintide, when taken alone by humans, triggered more than 3 ... CNNMoney.com Diabetes drug might help treat obesity - Sep 12, 2008 Pramlintide, currently approved by the FDA for diabetes to take in combination with insulin to ... Previous research also linked pramlintide to weight loss, ... China Post ë°”ë¥¸ì–¸ë¡ ë¹ ë¥¸ë‰´ìŠ¤ ì?¸í„°ë„· 연합뉴스 - Sep 5, 2007 ...(뉴욕 ë¡œì?´í„°=연합뉴스) ì œ2형(성ì?¸)당뇨병 ì¹˜ë£Œì œì?¸ 프람린티드(Pramlintide)ê°€ 칼로리 ì„취를 ì–µì œí•´ 체중ì?„ ê°?소시키는 효과가 있다는 연구결과가 나왔다. ... 연합뉴스 Primlintide/leptin combo produces 12.7% weight loss, says Amylin. - Nov 26, 2007 At study end, pramlintide/metreleptin treatment reduced body weight on average ... Subjects treated with pramlintide/metreleptin lost a median of 25 pounds ... $4.95 - Pharma Marketletter - ECNext SINTETSKI LIJEK PRAMLINTIDE - Sep 5, 2007 Lijek Pramlintide je sintetska verzija prirodnoga hormona amylina koji povećava osjećaj sitosti i smanjuje potrebu za unosom hrane. ... Javno.hr Ipratropium Bromide Inhl: Dosage, Uses and Warnings - Aug 31, 2006 MECHANISM OF ACTION: Pramlintide slows gastric emptying. ... CLINICAL EFFECTS: Concurrent use of pramlintide and anticholinergics may result in additive or ... Medscape Inside Drugmakers' War on Fat - Mar 6, 2008 When they were given the pramlintide/leptin combination, the extra pounds melted away. Christian Weyer, Amylin's executive director of clinical research, ... BusinessWeek Amylin Pharmaceuticals to Present Promising Data From Diabetes and … - Jun 2, 2008 Oral Late Breaker: "Pramlintide or Mealtime Insulin Added to Basal Insulin ... Oral: "Enhanced Weight Loss Following Co-Administration of Pramlintide with ... RedOrbit This CE program will improve participants' ability to: - Apr 1, 2006 Exenatide and pramlintide have very similar effects on the body, but act by very different ... Pramlintide is indicated for use only in Type 2 diabetes. ... Free with registration - Drug Formulary Review - AccessMyLibrary.com WEIGHT LOSS: WHY IT'S HARD; Keeping it off; Can't maintain that post-... - Jun 2, 2008 In 2005, Amylin produced a drug, pramlintide, that helps lower blood sugar ... Adding pramlintide "may sensitize the brain so it will work with leptin and ... Pay-Per-View - Los Angeles Times - ProQuest Archiver Atlanta health, diet and fitness news | ajc.com - Jun 4, 2005 Mid-stage clinical trials of the anti-obesity drug Pramlintide show it helped ... In a study of 204 obese people, those taking Pramlintide before meals for ... Atlanta Journal Constitution Article: Symlin.(NEW & APPROVED) - Internal Medicine News | … - Apr 15, 2005 Symlin.(NEW & APPROVED) ... find Internal Medicine News articles. Symlin (pramlintide, Amylin Pharmaceuticals Inc.) An antihyperglycemic drug for use at... Pay-Per-View - Internal Medicine News - HighBeam Research Press Release: FDA Approves SYMLIN Pen-Injector Devices Offering … - Oct 1, 2007 SAN DIEGO -- Amylin Pharmaceuticals, Inc. today ... the effects of SYMLIN(TM) (pramlintide ... Clinical Affairs for Amylin Pharmaceuticals. ... Pay-Per-View - PR Newswire - HighBeam Research Merger and Acquisition Scenario - Apr 7, 2007 Symlin (Pramlintide Acetate). Non-Insulin Dependent Diabetes Mellitus ... Symlin (Pramlintide Acetate). Phase I/Phase II Clinical Stage Products ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Jan 26, 2008 Symlin (Pramlintide Acetate). Phase I/Phase II Clinical Stage Products ... Buyer Products:. Second-Generation Amylinomimetic; PYY 3-36; Pramlintide ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - May 5, 2007 Symlin (Pramlintide Acetate). Non-Insulin Dependent Diabetes Mellitus ... Symlin (Pramlintide Acetate). Phase I/Phase II Clinical Stage Products ... $250.00 - Revere Reports - Revere … Initiates Phase 2B Dose-Ranging Clinical Study of Pramlintide/ … - May 5, 2008 Amylin Pharmaceuticals Initiates Phase 2B Dose-Ranging Clinical Study of Pramlintide/Metreleptin Combination Treatment in Obesity. from PR Newswire. Pay-Per-View - PR Newswire - HighBeam Research Risk management program for diabetes drug marks first year.(Metabolic... - Sep 1, 2006 This is a rate of 0.06 events per 1000 units or vials of pramlintide dispensed, ... Pramlintide, which is marketed by Amylin under the trade name Symlin, ... Pay-Per-View - Family Practice News - HighBeam Research AMYLIN EXPANDS OBESITY CLINICAL PROGRAM - Oct 30, 2006 Amylin Pharmaceuticals has presented Phase II data on pramlintide and announced an ... Four of the clinical studies will be conducted using pramlintide in ... Pay-Per-View - FDAnews Drug Pipeline Alert - Factiva, from Dow Jones New Diabetes Drugs Target Gut Hormones - Jul 26, 2006 Two such therapies, exenatide and pramlintide, were approved last year by the ... Pramlintide and exenatide belong to a new class of drugs called incretin ... Journal of American Medical Association - Journal of American Medical Association... The Worst Has Happened. Time to Sell? - Feb 10, 2005 Once described as "a typical cautionary tale from the biotech front" because of a seemingly devastatingly clinical failure with Pramlintide, the company now ... fool.com Amylin Pharmaceuticals, Inc. Investor Presentation at ADA - Part 4. - Jun 11, 2006 What is the best first step forward with pramlintide if we're going to combine ... And, also, I think the idea about how we go forward with pramlintide on a ... Free with registration - America's Intelligence Wire - AccessMyLibrary.com Diabetes Therapy; Amylin agonists show promise for diabetes treatment - Feb 21, 2005 ..."A stable analog, pramlintide, which has actions and pharmacokinetic and ... "The efficacy and safety of pramlintide administration has been tested in a ... Pay-Per-View - Diabetes Week - Factiva, from Dow Jones Diabetes Therapy; Findings in diabetes therapy provide new insights - Apr 11, 2005 ..."A stable analog, pramlintide, which has actions and pharmacokinetic and ... "The efficacy and safety of pramlintide administration has been tested in a ... Pay-Per-View - Proteomics Weekly - Factiva, from Dow Jones University of Aarhus; Findings in diabetes therapy provide new... - Apr 13, 2005 ..."A stable analog, pramlintide, which has actions and pharmacokinetic and ... "The efficacy and safety of pramlintide administration has been tested in a ... Pay-Per-View - Biotech Week - Factiva, from Dow Jones Merger and Acquisition Scenario - Mar 11, 2006 AC3056; AC2592 (Glucagon-Like Peptide 1 (GLP-1); SYMLIN (Pramlintide Acetate) ... SYMLIN (Pramlintide Acetate). Phase I/Phase II Clinical Stage Products ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Sep 2, 2006 AC2592 (Glucagon-Like Peptide 1 (GLP-1); SYMLIN (Pramlintide Acetate) ... SYMLIN (Pramlintide Acetate). Non-Insulin Dependent Diabetes Mellitus (NIDDM)/Type ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Jul 26, 2008 Symlin (Pramlintide Acetate). Non-Insulin Dependent Diabetes Mellitus ... Symlin (Pramlintide Acetate). Phase I/Phase II Clinical Stage Products ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Nov 29, 2008 Symlin (Pramlintide Acetate). Non-Insulin Dependent Diabetes Mellitus ... Symlin (Pramlintide Acetate). Phase I/Phase II Clinical Stage Products ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Oct 4, 2008 Symlin (Pramlintide Acetate). Non-Insulin Dependent Diabetes Mellitus ... Symlin (Pramlintide Acetate). Phase I/Phase II Clinical Stage Products ... $250.00 - Revere Reports - Revere Diabetes Therapy; New research in the area of diabetes therapy... - Jun 28, 2005 ..."A stable analog, pramlintide, which has actions and pharmacokinetic and ... "The efficacy and safety of pramlintide administration has been tested in a ... Pay-Per-View - Life Science Weekly - Factiva, from Dow Jones Press Release: Amylin Pharmaceuticals Announces Presentation of 12 … - Jun 6, 2005 In an Open-Label Clinical Study Pramlintide Lowered A1C, Body Weight, and Insulin Use in Patients With Type 2 Diabetes Failing to Achieve Glycemic Targets ... Pay-Per-View - PR Newswire - HighBeam Research |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines The Cancer News Network
COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy |
